- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie
- Status
- RECRUITING
- Phase
- N/A
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
- Status
- RECRUITING
- Phase
- N/A
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)
- Status
- WITHDRAWN
- Phase
- PHASE2
FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
- Status
- RECRUITING
- Phase
- PHASE2
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
- Status
- RECRUITING
- Phase
- NA
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan
- Status
- RECRUITING
- Phase
- NA